Aurinia Pharmaceuticals: HC Wainwright’s Q2 Earnings Estimate Unpacked
In a significant development for the biotechnology sector, analysts at HC Wainwright have released their comprehensive Q2 2025 earnings per share (EPS) estimates for Aurinia Pharmaceuticals Inc.,…